![Pascal Breton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Breton is the founder and former Chairman & CEO of VitamFero SA, which was founded in 2005.
He is also the founder of Virsol Groupe.
Dr. Breton's former positions include Chairman of Laboratoires UPSA SAS, Director of ConjuChem, Inc., Director of BioArtificial Gel Technologies, Inc., Director-Biotech Investment of Halisol Group BV, Director of Rimon Therapeutics Ltd., Director-Business Development of IDM Pharma SAS, Director of Aarmedis Corp., Manager-Key Account & Global Business Development of SGS SA, and Principal of National Institute of Health Policy.
Dr. Breton received a doctorate degree from Université d'Orléans in 1989.
| Företag | Position | Slut |
|---|---|---|
IDM Pharma SAS | Företagsledare/Principal | - |
| SGS SA | Företagsledare/Principal | - |
BioArtificial Gel Technologies, Inc.
 BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Direktör/Styrelseledamot | - |
Aarmedis Corp. | Direktör/Styrelseledamot | - |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs or pharmaceutical substances to treat Type 2 diabetes or other diagnostic substances | Direktör/Styrelseledamot | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 12 |
|---|---|
ConjuChem, Inc.
ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs or pharmaceutical substances to treat Type 2 diabetes or other diagnostic substances | Health Technology |
SGS SA
 SGS SA Miscellaneous Commercial ServicesCommercial Services Provides testing, inspection and certification services | Commercial Services |
Université d'Orléans
 Université d'Orléans Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
National Institute of Health Policy | |
Halisol Group BV
 Halisol Group BV Financial ConglomeratesFinance Function as investment holding company | Finance |
Rimon Therapeutics Ltd.
 Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medical polymers which helps to treat chronic wounds | Health Technology |
IDM Pharma SAS | |
VitamFero SA
 VitamFero SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and vaccines | Health Technology |
Laboratoires UPSA SAS | |
Virsol Groupe | |
Aarmedis Corp. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
